Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Operating Margin

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Meridian Bioscience VIVO is 30.48%. Meridian Bioscience's revenue for the same period is $184.04 million. The trailing-twelve-month operating margin at Trinity Biotech plc TRIB is 19.75%. Trinity Biotech's PEG ratio is 1.38. The trailing-twelve-month operating margin at Neogen NEOG is 19.61%. Neogen's ROE for the same period is 11.33%. The trailing-twelve-month operating margin at Abaxis ABAX is 13.21%. Abaxis had $85.54 million in total cash for the latest quarter.